pyrroles has been researched along with Goldblatt Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Fang, W; He, Y; Li, R; Li, Y; Wang, J; Xi, S; Zhang, B | 1 |
| Ceron, CS; Gerlach, RF; Guimarães, DA; Pinheiro, LC; Rizzi, E; Tanus-Santos, JE | 1 |
| Chen, YH; Yang, S; Zhou, JZ | 1 |
| Fukuda, N | 1 |
4 other study(ies) available for pyrroles and Goldblatt Syndrome
| Article | Year |
|---|---|
Differential expression of Nad(P)H oxidase isoforms and the effects of atorvastatin on cardiac remodeling in two-kidney two-clip hypertensive rats.
Topics: Animals; Atorvastatin; Atrial Natriuretic Factor; Blotting, Western; Fibrosis; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renovascular; Isoenzymes; Male; Membrane Glycoproteins; Myocardium; Myosin Heavy Chains; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Pyrroles; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension.
Topics: Animals; Aorta; Atorvastatin; Blood Pressure; Body Weight; Disease Models, Animal; Drug Therapy, Combination; Heptanoic Acids; Hypertension, Renovascular; Male; Nitric Oxide; Piperazines; Purines; Pyrroles; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides | 2013 |
[Effects of atorvastatin calcium on osteopontin in renovascular hypertensive rats].
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Heptanoic Acids; Hypertension, Renovascular; Male; Osteopontin; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |
Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines.
Topics: Amides; Animals; Base Sequence; Cardiovascular Diseases; DNA, Antisense; Gene Silencing; Genetic Therapy; Hypertension, Renovascular; Imidazoles; Kidney Diseases; Male; Oligonucleotides, Antisense; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Pyrroles; Rats; RNA, Catalytic; Swine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Intima | 2006 |